Remedent Announces Shareholder Conference Call to Be Held on Wednesday, February 15, 2012
13 February 2012 - 11:00PM
Marketwired
Remedent, Inc. ("Remedent" or the "Company") (OTCBB: REMI), an
international company specializing in research, development, and
the manufacturing of oral care and cosmetic products, announced
today that its management team will host a conference call on
Wednesday, February 15, to update investors on the recent strategic
developments.
Conference Call Information:
Date: Wednesday, February 15, 2012 Time: 10:00 am ET Toll Free:
888-378-4361 Toll: 719-325-2286 Passcode: 4519320
Replay Information:
Please dial in at least 10 minutes prior to the call to ensure
timely participation. A replay of the call will be available
through March 15, 2012.To listen, please call 888-203-1112 for toll
free or 719-457-0820. Utilize the pass code 4519320 for the
replay.
Additionally, a live and archived version of the earnings call
will be available at www.remedent.com. Please access the website
approximately 10 minutes prior to the start time in order to
download and install any necessary software.
About Remedent
Remedent, Inc. specializes in the research, development and
manufacturing and the marketing of oral care and cosmetic dental
products. The Company serves the professional dental industry with
breakthrough technology for dental veneers. These products are
supported by a line of professional veneer whitening and tooth
sensitivity solutions. Headquartered in Belgium, Remedent
distributes its products to more than 55 countries in the
worldwide. For more information, go to www.remedent.com.
Forward-Looking Statements
Statements in this press release that are "forward-looking
statements" are based on current expectations and assumptions that
are subject to risks and uncertainties. Such forward-looking
statements involve known and unknown risks, uncertainties and other
unknown factors that could cause Remedent's actual operating
results to be materially different from any historical results or
from any future results expressed or implied by such
forward-looking statements. In addition to statements that
explicitly describe these risks and uncertainties, readers are
urged to consider statements that contain terms such as "believes,"
"belief," "expects," "expect," "intends," "intend," "anticipate,"
"anticipates," "plans," "plan," "projects," "project," to be
uncertain and forward-looking. Actual results could differ
materially because of factors such as Remedent's ability to achieve
the synergies and value creation contemplated by the proposed
transaction. For further information regarding risks and
uncertainties associated with Remedent's business, please refer to
the risk factors described in Remedent's filings with the
Securities and Exchange Commission, including, but not limited to,
its annual report on Form 10-K and quarterly reports on Form 10-Q.
We undertake no duty to revise or update any forward-looking
statements to reflect events or circumstances after the date of
this press release.
For more information, please contact: Company Remedent,
Inc. Stephen Ross CFO Phone: +1-310-922-5685 E-mail:
docktor99@aol.com Investor Relations MZ Group Scott Powell
Senior Vice President Phone: +1-212-301-7130 E-mail:
scott.powell@hcinternational.net
Elysee Development (PK) (USOTC:ASXSF)
Historical Stock Chart
From Jun 2024 to Jul 2024
Elysee Development (PK) (USOTC:ASXSF)
Historical Stock Chart
From Jul 2023 to Jul 2024